DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 06 · Volume 49 · November 2016 DOI: 10.1055/s-006-32812 Special Issue Child/Adolescent Psychopharmacology

Editorial

217
Juckel, G.: Editorial to Child and Adolescence Psychopharmacology

Review

219
Kölch, M.; Plener, P. L.: Pharmacotherapy in Psychiatric Disorders of Children: Current Evidence and Trends

Commentary

226
Vitiello, B.: Pediatric Psychopharmacology
227
Holtmann, M.; Schimmelmann, B. G.: From Psychopharmacological Evidence to Clinical Practice: Unmet Needs in Child & Adolescent Psychiatry – Reflections on Kölch & Plener

Review

229
Lambert, M.; Niehaus, V.; Correll, C.: Pharmacotherapy in Children and Adolescents at Clinical-High Risk for Psychosis and Bipolar Disorder

Commentary

244
Birmaher, B.: The Challenge of Defining Prodromal Symptoms of Schizophrenia and Bipolar Disorders
246
Schimmelmann, B. G.; Holtmann, M.: Early Intervention in Psychosis and Bipolar Disorder in Children and Adolescents – Reflections on Lambert, Niehaus and Correll

Original Paper

248
Blázquez, A.; Gassó, P.; Mas, S.; Plana, M. T.; Lafuente, A.; Lázaro, L.: One-Year Follow-up of Children and Adolescents with Major Depressive Disorder: Relationship between Clinical Variables and Abcb1 Gene Polymorphisms
254
Trinczek, E.; Heinzel-Gutenbrunner, M.; Haberhausen, M.; Bachmann, C. J.: Time to Initiation of Clozapine Treatment in Children and Adolescents with Early-Onset Schizophrenia

Letter to the Editor

260
Naudet, F.: Comparing Nalmefene and Naltrexone in Alcohol Dependence: Is there a Spin?
261
Soyka, M.; Friede, M.; Schnitker, J.: Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-analysis – Comment to Naudet
262
Langgartner, S.; Strube, W.; Oviedo, T.; Hansbauer, M.; Karch, S.; Wirth, S.; Falkai, P.; Hasan, A.: Treatment-resistant Schizophrenia and Global Cortical Atrophy in a Patient with Turner Syndrome